{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:01:42Z","timestamp":1791090102459,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2010,10,8]],"date-time":"2010-10-08T00:00:00Z","timestamp":1286496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013238","type":"journal-article","created":{"date-parts":[[2010,10,8]],"date-time":"2010-10-08T14:59:02Z","timestamp":1286549942000},"page":"e13238","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice"],"prefix":"10.1371","volume":"5","author":[{"given":"Andrea","family":"Mencarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Renga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Francisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Distrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,10,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJM199804303381808","article-title":"HIV-protease inhibitors.","volume":"338","author":"C Flexner","year":"1998","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2005.11.021","article-title":"Update on HAART in HIV.","volume":"44","author":"P Yeni","year":"2006","journal-title":"Journal of Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/00002030-200304001-00009","article-title":"Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease?","volume":"17","author":"V Mooser","year":"2003","journal-title":"AIDS"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals.","volume":"33","author":"JS Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.","volume":"351","author":"A Carr","year":"1998","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/00126334-200010001-00002","article-title":"Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review.","volume":"25","author":"NM Graham","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00075197-200103000-00003","article-title":"Hyperlipidemia and inhibitors of HIV protease.","volume":"4","author":"O Distler","year":"2001","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1568006054553444","article-title":"Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.","volume":"5","author":"G Barbaro","year":"2005","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","article-title":"HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus.","volume":"276","author":"TM Riddle","year":"2001","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1124\/mol.104.010165","article-title":"Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors.","volume":"67","author":"RA Parker","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/mol.105.012898","article-title":"HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease.","volume":"68","author":"H Zhou","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200316261","article-title":"HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.","volume":"111","author":"J Dressman","year":"2003","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00041433-200010000-00006","article-title":"CD36 and atherosclerosis.","volume":"11","author":"RL Silverstein","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids.","volume":"284","author":"M Makishima","year":"1999","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis.","volume":"102","author":"CJ Sinal","year":"2000","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1194\/jlr.M800619-JLR200","article-title":"Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR\u2212\/\u2212 and apoE\u2212\/\u2212 mice.","volume":"50","author":"HB Hartman","year":"2009","journal-title":"J Lipid Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"H272","DOI":"10.1152\/ajpheart.01075.2008","article-title":"Antiatherosclerotic effect of farnesoid X receptor.","volume":"296","author":"A Mencarelli","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.","volume":"113","author":"M Watanabe","year":"2004","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.","volume":"103","author":"Y Zhang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M001602","article-title":"FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats.","volume":"51","author":"S Cipriani","year":"2010","journal-title":"J Lipid Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.1978.tb01632.x","article-title":"Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.","volume":"5","author":"MC Bateson","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(74)91134-9","article-title":"Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia.","volume":"2","author":"NE Miller","year":"1974","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","article-title":"Sterol regulatory element binding proteins transcriptional regulators of lipid synthetic genes.","volume":"40","author":"H Shimano","year":"2001","journal-title":"Progress Lipid Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1074\/jbc.M110158200","article-title":"Dual promoter structure of mouse and human fatty acid translocase\/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands.","volume":"277","author":"O Sato","year":"2002","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-gamma.","volume":"93","author":"L Nagy","year":"1998","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plipres.2009.11.001","article-title":"Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.","volume":"49","author":"S Fiorucci","year":"2010","journal-title":"Prog Lipid Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1194\/jlr.M500390-JLR200","article-title":"Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.","volume":"46","author":"EA Hanniman","year":"2005","journal-title":"J Lipid Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMe078037","article-title":"Cardiovascular Risks of Antiretroviral Therapy.","volume":"356","author":"JH Stein","year":"2007","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction.","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV protease inhibitors stimulate hepatic triglyceride synthesis.","volume":"20","author":"JM Lenhard","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1534-5807(02)00187-9","article-title":"Redundant pathways for negative feedback regulation of bile acid production.","volume":"2","author":"L Wang","year":"2002","journal-title":"Dev Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.21632","article-title":"Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver.","volume":"46","author":"J Huang","year":"2007","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/sj.emboj.7600728","article-title":"Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP.","volume":"24","author":"K Boulias","year":"2005","journal-title":"EMBO J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis.","volume":"8","author":"CJ Binder","year":"2002","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis.","volume":"420","author":"P Libby","year":"2002","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1073\/pnas.0400046101","article-title":"Expression and activation of the farnesoid X receptor in the vasculature.","volume":"101","author":"D Bishop-Bailey","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/ATVBAHA.107.152694","article-title":"Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.","volume":"27","author":"YT Li","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-\u03baB and AP-1.","volume":"274","author":"P Delerive","year":"1999","journal-title":"J Bio Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2006.11.021","article-title":"Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse.","volume":"195","author":"AC Calkin","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00125-005-0102-6","article-title":"Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation.","volume":"49","author":"AC Calkin","year":"2006","journal-title":"Diabetologia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2006.11.021","article-title":"Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse.","volume":"195","author":"AC Calkin","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00041433-200110000-00003","article-title":"Class A scavenger receptors, macrophages, and Atherosclerosis.","volume":"12","author":"MF Linton","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2001.tb03943.x","article-title":"Scavenger receptors, oxidized LDL, and atherosclerosis.","volume":"947","author":"A Boullier","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00041433-200502000-00005","article-title":"ATP-binding cassette transporter AI and its role in HDL formation.","volume":"16","author":"JY Lee","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway.","volume":"28","author":"J Zhou","year":"2006","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"19081","DOI":"10.1074\/jbc.M600116200","article-title":"Pregnane X receptor is a target of farnesoid X receptor.","volume":"28","author":"D Jung","year":"2006","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T13:56:55Z","timestamp":1591970215000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013238"}},"subtitle":[],"editor":[{"given":"Maurizio","family":"Pesce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,8]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013238","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,8]]}}}